- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Epidemiologic studies.
Displaying page 1 of 1.
EudraCT Number: 2016-001180-36 | Sponsor Protocol Number: 2015-2158 | Start Date*: 2016-12-01 |
Sponsor Name:Rijnstate Hospital | ||
Full Title: Short-term Efficacy of Stellate Ganglion Block to reduce Hot Flushes | ||
Medical condition: Hot Flushes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001176-67 | Sponsor Protocol Number: MEC-66108-2007 | Start Date*: 2009-10-16 | |||||||||||
Sponsor Name:Dr. Antonio Osuna Ortega | |||||||||||||
Full Title: Biodisponibilidad de quercetina bajo distintas formas de administración y sus implicaciones sobre el efecto antihipertensivo | |||||||||||||
Medical condition: Several epidemiologic studies have reported an inverse association between dietary flavonoid intake and mortality related to ischaemic heart disease. Our studies show that quercetin, the main dieta... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002219-69 | Sponsor Protocol Number: CHUBX2019/49 | Start Date*: 2021-07-19 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Long-term iron chelation in the prevention of secondary degeneration after cerebral infarction | ||
Medical condition: Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004905-29 | Sponsor Protocol Number: TMC435HPC3014 | Start Date*: 2013-08-19 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro... | |||||||||||||
Medical condition: Hepatitis C Virus (HCV) genotype-1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) AT (Completed) IT (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
